Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502174 · ClinicalTrials.gov registry record
FreeStyle Libre Glucose Monitoring System in Pediatric Populations
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 63
- Enrollment target
NCT03502174: Completed study, sponsored by Abbott Diabetes Care.
NCT03502174 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03502174 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
This study is a non-randomized, single-arm, multi-center study that is designed to evaluate the safety and effectiveness of the FreeStyle Libre Flash Glucose Monitoring Systems in pediatric populations.
Primary Outcome
System performance will be characterized with respect to YSI reference venous plasma sample measurements. Point accuracy of the system will be evaluated as the proportion of System readings that are within ±20% of the YSI reference value for YSI glucose levels ≥ 80 mg/dl and within ±20 mg/dl for YSI glucose levels \<80 mg/dl.
Interventions
- DEVICE FreeStyle Libre Flash Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-04-05 |
| Est. Completion | 2018-07-03 |
What the finished NCT03502174 record still lists
NCT03502174 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre Flash Glucose Monitoring System is the first listed.
NCT03502174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03502174 about?
NCT03502174 is a clinical study titled "FreeStyle Libre Glucose Monitoring System in Pediatric Populations". This study is a non-randomized, single-arm, multi-center study that is designed to evaluate the safety and effectiveness of the FreeStyle Libre Flash Glucose Monitoring Systems in pediatric populations.
What is the current status of trial NCT03502174?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2018-04-05. Estimated completion is 2018-07-03.
What interventions are being tested in trial NCT03502174?
The interventions under investigation include: FreeStyle Libre Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT03502174?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI